Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...
New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...
Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...
Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS New ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...
For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...
HNL Lab Medicine will expand its service footprint in Northeastern Pennsylvania with the opening of a new Patient Service Cen ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...
The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results